期刊文献+

不同促排卵方案在高龄卵巢储备功能低下人群中的应用研究 被引量:14

Application of different ovulation stimulation protocols in patients of advanced age with diminished ovarian reserve
原文传递
导出
摘要 目的探讨不同促排卵方案在波塞冬组4即高龄卵巢储备功能低下人群中的应用效果。方法对2018年1月至2021年2月在郑州大学第二附属医院生殖医学中心接受体外受精/卵胞浆内单精子注射(IVF/ICSI)治疗的高龄卵巢储备功能低下患者的423个周期的临床资料进行回顾性分析,根据促排卵方案的不同分为高孕激素状态下促排卵(PPOS)组(A组,149个周期)、微刺激组(B组,167个周期)和拮抗剂组(C组,107个周期)。比较各组的一般资料、实验室及临床相关指标等。结果人绒毛膜促性腺激素(hCG)日黄体生成素(LH)水平及早发LH峰率A组[(4.35±2.98)U/L,5.37%(8/149)]<C组[(6.69±5.98)U/L,21.50%(23/107)]<B组[(9.52±7.79)U/L,34.73%(58/167)](均P<0.001);获卵数及可利用胚胎数(个)A组[2.53±1.71,1(1,2)]高于B组[1.89±1.91,1(0,1)](均P<0.05);每获1个卵所需费用及每获1个可利用胚胎所需费用C组[(8292.11±4849.57)元,(11716.77±4528.57)元]最高,大于A组[(5844.12±3354.69)元,(8948.35±3668.06)元](P=0.001,P<0.001)及B组[(5428.42±3031.60)元,(8334.23±3170.11)元](均P<0.001)。结论对于行IVF/ICSI治疗的35岁及以上卵巢储备功能低下的患者,PPOS方案在获得更多的获卵数及可利用胚胎数的同时,经济成本更低,是一种相对理想的促排卵方案。拮抗剂方案能够降低时间成本,可以作为对妊娠有迫切需求患者的优选。 Objective To investigate the application effect of different ovulation stimulation protocols in POSEIDEN group 4,a population with diminished ovarian reserve and elderly age.Methods A Retrospective analysis of the clinical data of 423 cycles was made,which were from patients at advanced age with diminished ovarian reserve who received IVF/ICSI in Reproduction Medicine Center of the Second Affiliated Hospital of Zhengzhou University from January 2018to February 2021.The cycles were divided into progestin-primed ovarian stimulation group(group A,149 cycles),microstimulation group(B group,167 cycles)and GnRH antagonist protocol(C group,107 cycles).The general data,laboratory results and clinical indicators of each group were compared.Results The level of LH on HCG days and the rate of early LH surge were:A group[(4.35±2.98)U/L,5.37%(8/149)]<C group[(6.69±5.98)U/L,21.50%(23/107)]<B group[(9.52±7.79)U/L,34.73%(58/167)](P<0.001,P<0.001).The number of oocytes obtained and the number of available embryos in A group[2.53±1.71,1(1,2)]were remarkably higher than those in B group[1.89±1.91,1(0,1)](P<0.05).The cost for each obtained oocyte and the cost for each available embryo in C group[(8292.11±4849.57)yuan,(11716.77±4528.57)yuan ]were higher than that in A group[(5844.12±3354.69)yuan,(8948.35±3668.06)yuan](P=0.001,P<0.001)and B group[(5428.42±3031.60)yuan,(8334.23±3170.11)yuan](P<0.001,P<0.001).Conclusions For patients over 35 with diminished ovarian reserve who accept IVF/ICSI treatment,PPOS protocol,which is a relatively ideal ovarian protocol,can get more oocytes and available embryos with lower cost.GnRH antagonist protocol can reduce the time cost and may be preferred for patients with urgent need for pregnancy.
作者 徐小娅 禹果 程兰兰 谭丽 赵冬梅 XU Xiao-ya;YU Guo;CHENG Lan-lan;TAN Li;ZHAO Dong-mei(Reproductive Medical Center,the Second Affiliated Hospital of Zhengzhou University,Zhengzhou 450014,China)
出处 《中国实用妇科与产科杂志》 CAS CSCD 北大核心 2022年第12期1219-1223,共5页 Chinese Journal of Practical Gynecology and Obstetrics
基金 吴阶平医学基金会临床科研专项资助基金[320.6750.18558(9)] 郑州市科技惠民计划(2019KJHM0008)。
关键词 体外受精-胚胎移植 高龄 卵巢储备功能低下 早发黄体生成素峰 高孕激素状态下促排卵方案 in vitro fertilization-embryo transfer advanced-age diminished ovarian reserve early lh surge progestin-primed ovarian stimulation protocol
  • 相关文献

参考文献9

二级参考文献109

  • 1卢伟英,刘西茹,黄元华,徐雯,云日明,潘曼玲.718周期夫精宫腔内人工授精临床因素分析[J].海南医学院学报,2006,12(4):310-313. 被引量:16
  • 2管玉涛,蔡莲莲.围绝经期及绝经与性功能障碍[J].国外医学(计划生育.生殖健康分册),2007,26(3):149-151. 被引量:8
  • 3Fowler PA, Sorsa-Leslie T, Harris W, et al. Ovarian gona- dotrophin surge-attenuating factor (GnSAF) :where are we after 20 years of research? [ J ]. Reproduction, 2003,126 (6) :689-699.
  • 4Karligiotou E, Kollia P, Papaggeli P, et al. FSH modulatory effect on human granulosa cells:a gene-protein candidate for gonadotrophin surge-attenuating factor [ J ]. Reprod Bi- omed Online,2011,23 (4) :440-448.
  • 5Dafopoulos K, Kotsovassilis CG, Milingos S, et al. Changes in pituitary sensitivity to GnRH in estrogen-treated post- menopausal women:evidence that gonadotrophin surge at- tenuating factor plays a physiological role [ J ]. Hum Re- prod ,2004,19 (9) : 1985-1992.
  • 6Schuiling GA, Valkhof N, Koiter TR. FSH inhibits the aug- mentation by oestradiol of the pituitary responsiveness to GnRH in the female rat[ J]. Hum Reprod, 1999,14 (1) : 21-26.
  • 7Martinez F, Barri PN, Coroleu B, et al. Women with poor response to IVF have lowered circulating gonadotrophin surge-attenuating factor (GnSAF) bioactivity during spon- taneous and stimulated cycles[ J]. Hum Reprod,2002,17 (3) :634-640.
  • 8Messinis IE. Ovarian feedback, mechanism of action and possible clinical implications [ J ]. Hum Reprod Update, 2006,12(5) :557-571.
  • 9Allahbadia G. Does the addition of gonadotropin-releasing hormone analogs improve the pregnancy rates in intrau- terine insemination? [ J]. J Obstet Gynaecol India, 2011,61 (3) :261-264.
  • 10Gordon A, Aguilar R, Garrido-Gracia JC, et al. Human follicular fluid from superovulated women inhibits pro- gesterone receptor-dependent gonadotropin-releasing hormone self-priming in an estrous cycle-dependent manner in the rat [ J ]. J Endocrinol Invest, 2010, 33 (8) :564-570.

共引文献168

同被引文献103

引证文献14

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部